Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31.

作者: Anne-Marie Lamhonwah , Cameron Ackerley , Russell Onizuka , Aina Tilups , Daniel Lamhonwah

DOI: 10.1016/J.BBRC.2005.09.170

关键词:

摘要: Campylobacter jejuni and Mycobacterium paratuberculosis have been implicated in the pathogenesis of Crohn's disease. The presence bacterial metabolites colonic lumen causing a specific breakdown fatty acid oxidation epithelial cells has suggested as an initiating event inflammatory bowel disease (IBD). l-Carnitine is small highly polar zwitterion that plays essential role ATP generation intestinal bioenergetic metabolism. organic cation/carnitine transporters, OCTN1 OCTN2, function primarily transport l-carnitine elimination cationic drugs intestine. High-resolution linkage disequilibrium mapping identified region about 250kb size at 5q31 (IBD5) encompassing -2 genes, to confer susceptibility Recently, two variants OCTN2 genes shown form haplotype which associated with Crohn's. We show are strongly expressed target areas for IBD such ileum colon. Further, we now nine amino epitope shared by this functional variant (Leu503Phe) (which decreases efficiency carnitine transport), C. (9 aa) M. (6 aa). prevalence (Phe503:Leu503) 3-fold lower unaffected individuals Jewish origin (1:3.44) compared non-Jewish (1:1). hypothesize antibody raised during or enterocolitis would cross-react cell OCTN1, already less efficient transporter, leading impairment mitochondrial beta-oxidation may then serve IBD. This respond high-dose therapy.

参考文章(74)
W. E. Roediger, S. Nance, Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. British journal of experimental pathology. ,vol. 67, pp. 773- 782 ,(1986)
Stefania Anna Lucia Zanetti, Francesco Tanda, Amelia Lissia, Giovanni Fadda, Leonardo Antonio Sechi, Manuela Mura, Mycobacterium avium sub. paratuberculosis in tissue samples of Crohn's disease patients. New Microbiologica. ,vol. 27, pp. 75- 77 ,(2004)
Shoshana Zevin, Marci E. Schaner, Nicholas P. Illsley, Kathleen M. Giacomini, Guanidine Transport in a Human Choriocarcinoma Cell Line (JAR) Pharmaceutical Research. ,vol. 14, pp. 401- 405 ,(1997) , 10.1023/A:1012022810550
Kent D. Taylor, Jerome I. Rotter, Yang Huiying, Genetics of inflammatory bowel disease Inflammatory Bowel Disease: From Bench to Bedside. pp. 21- 65 ,(2003) , 10.1007/0-387-25808-6_3
Y Valles-Ayoub, L K Gordon, J Braun, L S Berberian, S R Targan, Expression of a novel autoantibody defined by the VH3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis. Journal of Immunology. ,vol. 153, pp. 3756- 3763 ,(1994)
S.V. Pande, R. Parvin, Carnitine-acylcarnitine translocase catalyzes an equilibrating unidirectional transport as well Journal of Biological Chemistry. ,vol. 255, pp. 2994- 3001 ,(1980) , 10.1016/S0021-9258(19)85841-6
John D. Rioux, Mark J. Daly, Mark S. Silverberg, Kerstin Lindblad, Hillary Steinhart, Zane Cohen, Terrye Delmonte, Kerry Kocher, Katie Miller, Sheila Guschwan, Edward J. Kulbokas, Sinead O'Leary, Ellen Winchester, Ken Dewar, Todd Green, Valerie Stone, Christine Chow, Albert Cohen, Diane Langelier, Gilles Lapointe, Daniel Gaudet, Janet Faith, Nancy Branco, Shelley B. Bull, Robin S. McLeod, Anne M. Griffiths, Alain Bitton, Gordon R. Greenberg, Eric S. Lander, Katherine A. Siminovitch, Thomas J. Hudson, Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nature Genetics. ,vol. 29, pp. 223- 228 ,(2001) , 10.1038/NG1001-223
Roser Pons, Rosalba Carrozzo, Ingrid Tein, Winsome F Walker, Linda J Addonizio, William Rhead, Armand F Miranda, Salvatore Dimauro, Darryl C De Vivo, Deficient Muscle Carnitine Transport in Primary Carnitine Deficiency Pediatric Research. ,vol. 42, pp. 583- 587 ,(1997) , 10.1203/00006450-199711000-00005